The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments - Reportlinker Review
NEW YORK, Oct. 14, 2015 /PRNewswire/ -- Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.
Highlights
- The U.S. market for biodefense-related rapid pathogen detection devices was valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 to reach $248 million by 2016 and $364 million by 2021.
- Detection devices are projected to grow at a CAGR of 5.2% from $155 million by 2016 to $200 million by 2021.
- The sensors devices market is projected to reach $93 million by 2016. It is projected to increase at a CAGR of 12% and reach $164 million by 2021.
Introduction & Scope
INTRODUCTION
REASONS FOR DOING THE STUDY
The U.S. found itself in the unusual position of being attacked by a foreign entity in 2001, and preparations for such an attack were woefully inadequate. Since then, the U.S. government has given priority to preparations for potential biological attacks by incentivizing industry and academia to develop pathogen identification and treatment products. Pathogenic agents can be viruses, bacteria, fungi, protozoa, parasites, or manufactured toxins. They are able to cause diseases in plants, animals and humans. Pathogens that are harmful to animals and plants are not covered unless they pose eminent danger to humans through consumption. Examples of infectious agents discussed include smallpox, anthrax, plague and tularemia. Another area of pathogen identification includes potentially harmful chemical toxins that are used in biological warfare situations. These include ricin and botulin.
The market for biodefense-related rapid pathogen identification products continues to expand with an emphasis on products that are more portable, easy to use, sensitive and accurate. Multiple assays are being field-tested and used by military personnel, first responders, industry and businesses. The purpose for this report is to provide an overview of the industry and its participants, and project the growth of the market through 2021.
STUDY GOALS AND OBJECTIVES
Biological substances that can be weaponized for either civilian or military destruction are considered biodefense related, and identifying these substances accurately and rapidly is at the heart of this report. Additionally, treatment methods such as vaccines and pharmaceuticals will be discussed. The report concentrates on the U.S. biodefense-related rapid pathogen identification and treatment markets.
This report is intended to:
- Provide an accurate overview of the biological warfare landscape and the infectious agents that could pose the most acute problems.
- Discuss the pathogen identification products currently on the market and their potential for growth.
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Provide an overview of recently issued patents related to biological rapid pathogen identification.
- Include a comprehensive directory of manufacturers of assays, sensors, vaccines and pharmaceuticals used
INTENDED AUDIENCE
This new report on the biodefense-related rapid pathogen identification and treatment market will be a valuable tool for decision makers and manufacturers in biodefense rapid pathogen diagnostic, vaccine and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies and university laboratories will find valuable information on the U.S. biodefense market, and individuals involved in strategic planning, marketing and sales development will appreciate the specificity of the report. Additionally, emphasis on the type of disease, major players in the marketplace, market conditions, and current and projected revenues will be provided.
SCOPE AND FORMAT
The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay,
sensor, vaccine and treatment companies.
Read the full report: http://www.reportlinker.com/p03326180-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article